IMS Health was accused of “anticompetitive actions” over pharmaceutical data markets in an antitrust complaint filed by its top competitor Symphony Health Solutions, according to the Courthouse News Service on Friday. IMS Health, based in Pennsylvania, supplies health data to pharmaceutical and biotech companies to generate drug prescription and consumption predictions. Symphony is suing, claiming IMS Health cost it millions in sales and negatively affected its customers, allegedly scheming to monopolize over the industry and in turn preventing Symphony from getting a hold of 80 percent of generated data by long-term care facilities. The lawsuit also indicated that IMS Health operates in most continents, maintained “exclusive relationships” with other data suppliers, and holds a history of anticompetitive behavior. Symphony claimed that IMS Health had succeeded or tried to succeed in taking over the targeting and compensation data market, the managed market data market, the integrated global data market, and the anonymous patient longitudinal data market. Due to these violations, Symphony is seeking an “injunction, lost profits, and treble damages
Full Content: Courthouse News Service
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI